Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3856968 | Journal of Renal Nutrition | 2008 | 6 Pages |
Abstract
High levels of homocysteine have been implicated as a cardiovascular risk factor in the general population and in patients with chronic renal failure, and particularly patients on hemodialysis. To classify a risk factor as causally related to a certain disease, both strong epidemiologic data and sound basic-science studies establishing a mechanism are needed. Among the latter, the hypomethylation of proteins and DNA, and protein homocysteinylation, have been investigated in uremia, providing for an array of toxic effects in this disease.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Alessandra F. MD, PhD, Maria Grazia BS, Paola BS, Ersilia MD, PhD, Rosanna BS, Cinzia BS, PhD, Diego MD, PhD, Natale G. MD,